hydroxyindoleacetic acid has been researched along with Substance Withdrawal Syndrome in 54 studies
(5-hydroxyindol-3-yl)acetic acid : A member of the class of indole-3-acetic acids that is indole-3-acetic acid substituted by a hydroxy group at C-5.
Substance Withdrawal Syndrome: Physiological and psychological symptoms associated with withdrawal from the use of a drug after prolonged administration or habituation. The concept includes withdrawal from smoking or drinking, as well as withdrawal from an administered drug.
| Excerpt | Relevance | Reference |
|---|---|---|
| " We measured severity of depression with Beck's Depression Inventory (BDI) and Hamilton's Depression Rating Scale (HDRS), plasma concentrations of cortisol, DHEA and DHEA-S, and CSF concentrations of the serotonin metabolite 5-hydroxyindoleacetic acid (5-HIAA), the norepinephrine metabolite 3-methoxy-4-hydroxyphenylglycol (MHPG) and the dopamine metabolite homovanillic acid (HVA) in 21 abstinent alcoholics after 4 weeks of abstinence and in 11 age-matched healthy control subjects." | 7.70 | Severity of depression in abstinent alcoholics is associated with monoamine metabolites and dehydroepiandrosterone-sulfate concentrations. ( George, D; Heinz, A; Hommer, D; Linnoila, M; Weingartner, H; Wolkowitz, OM, 1999) |
| "Increased noradrenergic activity during chronic dopamine blockade may be an episode marker and may predict relapse within 6 weeks following haloperidol withdrawal in schizophrenia." | 7.69 | Noradrenergic activity and prediction of psychotic relapse following haloperidol withdrawal in schizophrenia. ( Agren, H; Gurklis, J; O'Connor, DT; Peters, JL; van Kammen, DP; Yao, JK, 1994) |
| "In the week prior to discontinuation of haloperidol treatment, global behavioral ratings and a lumbar puncture for cerebrospinal fluid monoamine metabolities were obtained in 88 patients with chronic schizophrenia." | 7.69 | Behavioral vs biochemical prediction of clinical stability following haloperidol withdrawal in schizophrenia. ( Gilbertson, MW; Gurklis, JA; Kelley, ME; Peters, JL; van Kammen, DP; Yao, JK, 1995) |
| "Caffeine was injected at doses of 80 mg/kg daily for five days." | 5.29 | 24h withdrawal following repeated administration of caffeine attenuates brain serotonin but not tryptophan in rat brain: implications for caffeine-induced depression. ( Haleem, DJ; Haleem, MA; Yasmeen, A; Zafar, A, 1995) |
| " We measured severity of depression with Beck's Depression Inventory (BDI) and Hamilton's Depression Rating Scale (HDRS), plasma concentrations of cortisol, DHEA and DHEA-S, and CSF concentrations of the serotonin metabolite 5-hydroxyindoleacetic acid (5-HIAA), the norepinephrine metabolite 3-methoxy-4-hydroxyphenylglycol (MHPG) and the dopamine metabolite homovanillic acid (HVA) in 21 abstinent alcoholics after 4 weeks of abstinence and in 11 age-matched healthy control subjects." | 3.70 | Severity of depression in abstinent alcoholics is associated with monoamine metabolites and dehydroepiandrosterone-sulfate concentrations. ( George, D; Heinz, A; Hommer, D; Linnoila, M; Weingartner, H; Wolkowitz, OM, 1999) |
| "Increased noradrenergic activity during chronic dopamine blockade may be an episode marker and may predict relapse within 6 weeks following haloperidol withdrawal in schizophrenia." | 3.69 | Noradrenergic activity and prediction of psychotic relapse following haloperidol withdrawal in schizophrenia. ( Agren, H; Gurklis, J; O'Connor, DT; Peters, JL; van Kammen, DP; Yao, JK, 1994) |
| "In the week prior to discontinuation of haloperidol treatment, global behavioral ratings and a lumbar puncture for cerebrospinal fluid monoamine metabolities were obtained in 88 patients with chronic schizophrenia." | 3.69 | Behavioral vs biochemical prediction of clinical stability following haloperidol withdrawal in schizophrenia. ( Gilbertson, MW; Gurklis, JA; Kelley, ME; Peters, JL; van Kammen, DP; Yao, JK, 1995) |
| "Withdrawal of caffeine however produced memory deficits and significantly increases the immobility time of rats in FST." | 1.38 | Altered brain serotonergic neurotransmission following caffeine withdrawal produces behavioral deficits in rats. ( Haider, S; Haleem, DJ; Khaliq, S; Naqvi, F; Perveen, T; Saleem, S, 2012) |
| "5-Hydroxytryptophol glucuronide was measured by ELISA with good analytical precision, its diagnostic specificity and sensitivity was better than that of 5-hydroxytryptophol and its correlation was closer to ethyl glucuronide than to 5-hydroxytryptophol." | 1.34 | Determination of glucuronidated 5-hydroxytryptophol (GTOL), a marker of recent alcohol intake, by ELISA technique. ( Beck, O; Borg, S; Borucki, K; Dierkes, J; Weinmann, W; Wiesbeck, G; Wolfersdorf, M; Wurst, FM, 2007) |
| "Caffeine was injected at doses of 80 mg/kg daily for five days." | 1.29 | 24h withdrawal following repeated administration of caffeine attenuates brain serotonin but not tryptophan in rat brain: implications for caffeine-induced depression. ( Haleem, DJ; Haleem, MA; Yasmeen, A; Zafar, A, 1995) |
| "Rats treated with haloperidol also showed an increase in 5-HIAA levels, possibly due to enhanced serotonin turnover." | 1.27 | Dopamine and serotonin metabolites in rat cerebroventricular fluid following withdrawal of haloperidol or electroshock treatment. ( Barkai, AI; Kowalik, S; Reches, A, 1984) |
| " Rats were made dependent on diazepam by the chronic administration of this drug in the diet." | 1.26 | Effect of p-chlorophenylalanine on diazepam withdrawal signs in rats. ( Fukumori, R; Kitagawa, H; Satoh, T; Suzuki, T; Yanaura, S; Yoshii, T, 1980) |
| "Severity of withdrawal symptoms assessed on a rating scale in 14 patients with 4 days or less of abstinence correlated marginally with HVA but not with 5-HIAA." | 1.26 | Factors influencing monoamine metabolites and tryptophan in patients with alcohol dependence. ( Banki, CM, 1981) |
| " The controls were comprised of naive rats (G-VI) and naive rats dosed in the same manner as the dependent rats." | 1.26 | Participant of serotonin turnover rate in the brain on barbital withdrawal convulsion. ( Hiramori, T; Nakao, K; Tagashira, E; Urano, T; Yanaura, S, 1982) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 29 (53.70) | 18.7374 |
| 1990's | 12 (22.22) | 18.2507 |
| 2000's | 8 (14.81) | 29.6817 |
| 2010's | 4 (7.41) | 24.3611 |
| 2020's | 1 (1.85) | 2.80 |
| Authors | Studies |
|---|---|
| Lee, EJ | 1 |
| Slotkin, TA | 1 |
| Card, J | 1 |
| Seidler, FJ | 1 |
| Natividad, LA | 1 |
| Tejeda, HA | 1 |
| Torres, OV | 1 |
| O'Dell, LE | 1 |
| Khaliq, S | 1 |
| Haider, S | 1 |
| Naqvi, F | 1 |
| Perveen, T | 1 |
| Saleem, S | 1 |
| Haleem, DJ | 2 |
| Okamoto, R | 1 |
| Itoh, Y | 1 |
| Murata, Y | 1 |
| Kobayashi, D | 1 |
| Hosoi, M | 1 |
| Mine, K | 1 |
| Heinz, A | 2 |
| Jones, DW | 1 |
| Bissette, G | 1 |
| Hommer, D | 2 |
| Ragan, P | 1 |
| Knable, M | 1 |
| Wellek, S | 1 |
| Linnoila, M | 3 |
| Weinberger, DR | 1 |
| Roy, A | 1 |
| Berman, J | 1 |
| Gonzalez, B | 1 |
| Roy, M | 1 |
| Diaz, SL | 1 |
| Kemmling, AK | 1 |
| Balerio, GN | 1 |
| Bull, EJ | 1 |
| Hutson, PH | 1 |
| Fone, KC | 1 |
| Taylor, BK | 1 |
| Basbaum, AI | 1 |
| El Ganouni, S | 1 |
| Hanoun, N | 1 |
| Boni, C | 1 |
| Tazi, A | 1 |
| Hakkou, F | 1 |
| Hamon, M | 1 |
| Carlson, JN | 1 |
| Drew Stevens, K | 1 |
| Dierkes, J | 1 |
| Wolfersdorf, M | 1 |
| Borucki, K | 1 |
| Weinmann, W | 1 |
| Wiesbeck, G | 1 |
| Beck, O | 1 |
| Borg, S | 1 |
| Wurst, FM | 1 |
| Barkai, AI | 1 |
| Kowalik, S | 1 |
| Reches, A | 1 |
| Gothóni, P | 1 |
| Ahtee, L | 4 |
| Fujimoto, A | 1 |
| Suzuki, T | 1 |
| Fukumori, R | 1 |
| Yoshii, T | 1 |
| Yanaura, S | 3 |
| Satoh, T | 1 |
| Kitagawa, H | 1 |
| Banki, CM | 1 |
| Tagashira, E | 2 |
| Hiramori, T | 2 |
| Urano, T | 2 |
| Nakao, K | 1 |
| Petursson, H | 1 |
| Bond, PA | 1 |
| Smith, B | 1 |
| Lader, MH | 1 |
| Mena, MA | 1 |
| Martín del Río, R | 1 |
| Herrera, E | 1 |
| Yasmeen, A | 1 |
| Haleem, MA | 1 |
| Zafar, A | 1 |
| van Kammen, DP | 3 |
| Agren, H | 1 |
| Yao, JK | 2 |
| O'Connor, DT | 1 |
| Gurklis, J | 1 |
| Peters, JL | 2 |
| San-Martin-Clark, O | 1 |
| Leza, JC | 1 |
| Lizasoain, I | 1 |
| Lorenzo, P | 1 |
| Kelley, ME | 1 |
| Gurklis, JA | 1 |
| Gilbertson, MW | 1 |
| Colado, MI | 1 |
| Alfaro, MJ | 1 |
| Lopez, F | 1 |
| Del Val, V | 1 |
| Martin, MI | 1 |
| Gil-Martín, E | 1 |
| Colado, I | 1 |
| Fernández-López, A | 1 |
| Fernández-Briera, A | 1 |
| Calvo, P | 1 |
| Javelle, N | 1 |
| Renaud, B | 1 |
| Lambás-Señas, L | 1 |
| Uchimura, N | 1 |
| Nakamura, J | 1 |
| Hildebrand, BE | 2 |
| Nomikos, GG | 2 |
| Hertel, P | 1 |
| Schilström, B | 1 |
| Svensson, TH | 2 |
| Wallgren, H | 1 |
| Kosunen, AL | 1 |
| Petrakis, IL | 1 |
| Trevisan, L | 1 |
| D'Souza, C | 1 |
| Gil, R | 1 |
| Krasnicki, S | 1 |
| Webb, E | 1 |
| Heninger, G | 1 |
| Cooney, N | 1 |
| Krystal, JH | 1 |
| Panagis, G | 1 |
| Weingartner, H | 1 |
| George, D | 1 |
| Wolkowitz, OM | 1 |
| Agarwal, RA | 1 |
| Lapierre, YD | 1 |
| Rastogi, RB | 1 |
| Singhal, RL | 1 |
| Winsberg, BG | 1 |
| Hurwic, MJ | 1 |
| Perel, J | 1 |
| Tabakoff, B | 2 |
| Hoffman, P | 1 |
| Moses, F | 1 |
| Benwell, ME | 1 |
| Balfour, DJ | 2 |
| Kato, N | 2 |
| Takahashi, S | 2 |
| Tani, N | 2 |
| Iwase, N | 1 |
| Odani, K | 1 |
| Hoffman, PL | 1 |
| Siever, L | 1 |
| Kraemer, H | 1 |
| Sack, R | 1 |
| Angwin, P | 1 |
| Berger, P | 1 |
| Zarcone, V | 1 |
| Barchas, J | 1 |
| Brodie, HK | 1 |
| Modai, I | 1 |
| Beigel, Y | 1 |
| Cygielman, G | 1 |
| Attila, P | 1 |
| Lauhakangas, V | 1 |
| Solkinen, A | 1 |
| Sipilä, J | 1 |
| Copland, AM | 1 |
| Attila, LM | 1 |
| Carlson, KR | 1 |
| Haikala, H | 1 |
| Nardoni, A | 1 |
| Di Piazza, V | 1 |
| Moretti, V | 1 |
| Copetti, R | 1 |
| Trinco, G | 1 |
| Peters, J | 1 |
| van Kammen, WB | 1 |
| Nugent, A | 1 |
| Goetz, KL | 1 |
| Yao, J | 1 |
| Bagdy, G | 1 |
| Perényi, A | 1 |
| Frecska, E | 1 |
| Révai, K | 1 |
| Papp, Z | 1 |
| Fekete, MI | 1 |
| Arató, M | 1 |
| Papeschi, R | 1 |
| Theiss, P | 1 |
| Herz, A | 1 |
| Yamane, H | 1 |
| Kondo, H | 1 |
| Tonge, SR | 1 |
| Turnbull, MJ | 1 |
| Ballinger, BR | 1 |
| Shen, FH | 1 |
| Loh, HH | 1 |
| Way, EL | 1 |
1 review available for hydroxyindoleacetic acid and Substance Withdrawal Syndrome
| Article | Year |
|---|---|
[Changes in metabolism of catecholamines and serotonin during alcohol withdrawal].
Topics: Antidepressive Agents, Second-Generation; Dopamine; Ethanol; Homovanillic Acid; Humans; Hydroxyindol | 1997 |
53 other studies available for hydroxyindoleacetic acid and Substance Withdrawal Syndrome
| Article | Year |
|---|---|
Factors Predicting 6-Month Smoking Cessation in Korean Adults.
Topics: Adult; Cotinine; Female; Follow-Up Studies; Humans; Hydroxyindoleacetic Acid; Male; Middle Aged; Pro | 2020 |
Nicotine administration in adolescence reprograms the subsequent response to nicotine treatment and withdrawal in adulthood: sex-selective effects on cerebrocortical serotonergic function.
Topics: Aging; Animals; Cerebral Cortex; Female; Hydroxyindoleacetic Acid; Male; Nicotine; Nicotinic Agonist | 2014 |
Nicotine withdrawal produces a decrease in extracellular levels of dopamine in the nucleus accumbens that is lower in adolescent versus adult male rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Bicuculline; Dopamine; Extracellular Space; GABA Ant | 2010 |
Altered brain serotonergic neurotransmission following caffeine withdrawal produces behavioral deficits in rats.
Topics: Animals; Brain; Caffeine; Depression; Disease Models, Animal; Humans; Hydroxyindoleacetic Acid; Immo | 2012 |
Reduction of group II metabotropic glutamate receptors during development of benzodiazepine dependence.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Benzodiazepines; Cerebral Cortex; Dopamine; Flumazenil; GAB | 2013 |
Relationship between cortisol and serotonin metabolites and transporters in alcoholism [correction of alcolholism].
Topics: Adult; Affect; Alcoholism; Carrier Proteins; Case-Control Studies; Corticotropin-Releasing Hormone; | 2002 |
Cerebrospinal fluid monoamine metabolites in cocaine patients: no relationship to cue-induced craving.
Topics: Adult; Cocaine; Cocaine-Related Disorders; Cues; Dopamine; Female; Homovanillic Acid; Humans; Hydrox | 2002 |
Baclofen reestablishes striatal and cortical dopamine concentrations during naloxone-precipitated withdrawal.
Topics: Animals; Baclofen; Cerebral Cortex; Chromatography, High Pressure Liquid; Dopamine; Electrochemistry | 2003 |
Reduced social interaction following 3,4-methylenedioxymethamphetamine is not associated with enhanced 5-HT 2C receptor responsivity.
Topics: Animals; Brain; Corticosterone; Exploratory Behavior; Hydroxyindoleacetic Acid; Hypothermia; In Vitr | 2003 |
Systemic morphine-induced release of serotonin in the rostroventral medulla is not mimicked by morphine microinjection into the periaqueductal gray.
Topics: Analgesics, Opioid; Animals; Drug Administration Routes; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Fentan | 2003 |
Prevention of diazepam withdrawal syndrome by nifedipine-behavioural and neurochemical studies.
Topics: Animals; Anti-Anxiety Agents; Base Sequence; Behavior, Animal; Calcium Channel Blockers; Diazepam; D | 2004 |
Individual differences in ethanol self-administration following withdrawal are associated with asymmetric changes in dopamine and serotonin in the medial prefrontal cortex and amygdala.
Topics: 3,4-Dihydroxyphenylacetic Acid; Alcohol Drinking; Amygdala; Animals; Behavior, Animal; Central Nervo | 2006 |
Determination of glucuronidated 5-hydroxytryptophol (GTOL), a marker of recent alcohol intake, by ELISA technique.
Topics: Adult; Alcohol Drinking; Biomarkers; Enzyme-Linked Immunosorbent Assay; Glucuronides; Humans; Hydrox | 2007 |
Dopamine and serotonin metabolites in rat cerebroventricular fluid following withdrawal of haloperidol or electroshock treatment.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Dopamine; Electroshock; Haloperidol; Homovanillic Acid; Hum | 1984 |
Chronic ethanol administration decreases 5-HT and increases 5-HIAA concentration in rat brain.
Topics: Animals; Brain; Ethanol; Humans; Hydroxyindoleacetic Acid; Male; Probenecid; Rats; Serotonin; Stimul | 1980 |
[Cerebrospinal fluid monamine metabolites and cyclic nucleotides during alcoholic withdrawal syndrome].
Topics: Adult; Alcoholism; Brain; Cyclic AMP; Cyclic GMP; Female; Homovanillic Acid; Humans; Hydroxyindoleac | 1980 |
Effect of p-chlorophenylalanine on diazepam withdrawal signs in rats.
Topics: Animals; Body Weight; Brain Chemistry; Diazepam; Drug Synergism; Eating; Fenclonine; Humans; Hydroxy | 1980 |
Factors influencing monoamine metabolites and tryptophan in patients with alcohol dependence.
Topics: Alcoholism; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Kinetics; Phenylacetates; R | 1981 |
Participant of serotonin turnover rate in the brain on barbital withdrawal convulsion.
Topics: Animals; Barbital; Barbiturates; Brain; Chlorpromazine; Humans; Hydroxyindoleacetic Acid; Male; Nitr | 1982 |
Monoamine metabolism during chronic benzodiazepine treatment and withdrawal.
Topics: Adult; Anti-Anxiety Agents; Benzodiazepines; Double-Blind Method; Female; Glycols; Homovanillic Acid | 1983 |
Formation of physical dependence on barbiturates and cerebral monoamines.
Topics: alpha-Methyltyrosine; Animals; Barbital; Barbiturates; Biogenic Amines; Body Weight; Brain; Catechol | 1983 |
The effect of long-term ethanol maternal ingestion and withdrawal on brain regional monoamine and amino acid precursors in 15-day-old rats.
Topics: Alcoholism; Amino Acids; Animals; Biogenic Amines; Brain Chemistry; Catecholamines; Female; Humans; | 1984 |
24h withdrawal following repeated administration of caffeine attenuates brain serotonin but not tryptophan in rat brain: implications for caffeine-induced depression.
Topics: Analysis of Variance; Animals; Brain; Caffeine; Depression; Dose-Response Relationship, Drug; Drug A | 1995 |
Noradrenergic activity and prediction of psychotic relapse following haloperidol withdrawal in schizophrenia.
Topics: Adult; Chromogranin A; Chromogranins; Haloperidol; Homovanillic Acid; Humans; Hydroxyindoleacetic Ac | 1994 |
Changes induced by sodium cromoglycate on brain serotonin turnover in morphine dependent and abstinent mice.
Topics: Animals; Brain Chemistry; Chromatography, High Pressure Liquid; Cromolyn Sodium; Electrochemistry; H | 1993 |
Behavioral vs biochemical prediction of clinical stability following haloperidol withdrawal in schizophrenia.
Topics: Adult; Age of Onset; Haloperidol; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Logistic Mode | 1995 |
Effect of nimodipine, diltiazem and BAY K 8644 on the behavioural and neurochemical changes associated with naloxone-precipitated withdrawal in the rat. A comparison with clonidine.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1993 |
Effects of chronic treatment with ethanol and withdrawal on levels of monoamines in rat cerebral cortex and striatum. Influence of midazolam, thiopenthal and somatostatin.
Topics: Animals; Anti-Anxiety Agents; Biogenic Monoamines; Cerebral Cortex; Corpus Striatum; Ethanol; Hydrox | 1995 |
Monoamine metabolism in the locus coeruleus measured concurrently with behavior during opiate withdrawal: an in vivo microdialysis study in freely moving rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Analgesics, Opioid; Animals; Behavior, Animal; Biogenic Monoamines; | 1997 |
Reduced dopamine output in the nucleus accumbens but not in the medial prefrontal cortex in rats displaying a mecamylamine-precipitated nicotine withdrawal syndrome.
Topics: 3,4-Dihydroxyphenylacetic Acid; Analysis of Variance; Animals; Behavior, Animal; Dopamine; Homovanil | 1998 |
Technique for producing an alcohol withdrawal syndrome in rats.
Topics: Alcoholism; Animals; Behavior, Animal; Brain; Butanols; Disease Models, Animal; Ethanol; Heart Rate; | 1973 |
CSF monoamine metabolite and beta endorphin levels in recently detoxified alcoholics and healthy controls: prediction of alcohol cue-induced craving?
Topics: Adult; Alcoholism; Behavior, Addictive; Biogenic Monoamines; Biomarkers; Case-Control Studies; Ethan | 1999 |
Behavioral and biochemical manifestations of mecamylamine-precipitated nicotine withdrawal in the rat: role of nicotinic receptors in the ventral tegmental area.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Dopamine; Hydroxyindoleacetic Acid; Male; Mecamylamine; Mot | 1999 |
Severity of depression in abstinent alcoholics is associated with monoamine metabolites and dehydroepiandrosterone-sulfate concentrations.
Topics: Adult; Case-Control Studies; Dehydroepiandrosterone; Depression; Ethanol; Female; Homovanillic Acid; | 1999 |
Alterations in brain 5-hydroxytryptamine metabolism during the 'withdrawal' phase after chronic treatment with diazepam and bromazepam.
Topics: Animals; Anti-Anxiety Agents; Brain; Bromazepam; Diazepam; Humans; Hydroxyindoleacetic Acid; Male; M | 1977 |
Neurochemistry of withdrawal emergent symptoms in children.
Topics: Antipsychotic Agents; Child; Cyclic AMP; Dyskinesia, Drug-Induced; Homovanillic Acid; Humans; Hydrox | 1977 |
Neurochemical correlates of ethanol withdrawal: alterations in serotoninergic function.
Topics: Alcoholism; Animals; Brain Chemistry; Brain Stem; Humans; Hydroxyindoleacetic Acid; Male; Mice; Mice | 1977 |
Effects of nicotine administration and its withdrawal on plasma corticosterone and brain 5-hydroxyindoles.
Topics: Animals; Brain; Corticosterone; Hippocampus; Humans; Hydroxyindoleacetic Acid; Hypothalamus; Male; N | 1979 |
Changes in the metabolism of biogenic amines in alcoholism--especially regarding CSF monoamine metabolites and serum DBH activity.
Topics: Adult; Aged; Alcoholism; Biogenic Amines; Dopamine beta-Hydroxylase; Female; Homovanillic Acid; Huma | 1979 |
Measures of physical dependence and involvement of serotonin in withdrawal symptomatology.
Topics: Alcoholism; Animals; Body Temperature; Brain Chemistry; Humans; Hydroxyindoleacetic Acid; Mice; Mice | 1977 |
Gradients of biogenic amine metabolites in cerebrospinal fluid.
Topics: Alzheimer Disease; Amphetamine; Brain Diseases; Brain Neoplasms; Depression; Homovanillic Acid; Huma | 1975 |
Urinary amine metabolite excretion in a patient with adrenergic hyperactivity state: reaction to phenelzine withdrawal and combined treatment.
Topics: Bipolar Disorder; Delirium; Glycols; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Meta | 1986 |
The fall of homovanillic acid and 5-hydroxyindoleacetic acid concentrations in brains of mice withdrawn from repeated morphine treatment and their restoration by acute morphine administration.
Topics: Animals; Body Weight; Dopamine; Homovanillic Acid; Hydroxyindoleacetic Acid; Male; Mice; Morphine; M | 1987 |
The effects of diazepam on brain 5-HT and 5-HIAA in stressed and unstressed rats.
Topics: Altitude; Animals; Brain; Cerebral Cortex; Corticosterone; Diazepam; Habituation, Psychophysiologic; | 1987 |
Changes in brain monoamine metabolism during withdrawal from chronic oral self-administration of morphine and in response to a morphine challenge in the withdrawn state.
Topics: 3,4-Dihydroxyphenylacetic Acid; Administration, Oral; Animals; Biogenic Amines; Brain; Dopamine; Hyd | 1989 |
[Is serotonin implicated in the pathogenesis of the alcohol abstinence syndrome?].
Topics: Adult; Aged; Alcohol Withdrawal Delirium; Ethanol; Female; Hallucinations; Humans; Hydroxyindoleacet | 1989 |
CSF norepinephrine in schizophrenia is elevated prior to relapse after haloperidol withdrawal.
Topics: Adult; Chromatography, High Pressure Liquid; Chronic Disease; Haloperidol; Homovanillic Acid; Humans | 1989 |
Decrease in dopamine, its metabolites and noradrenaline in cerebrospinal fluid of schizophrenic patients after withdrawal of long-term neuroleptic treatment.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adult; Antipsychotic Agents; Chronic Disease; Dopamine; Female; Halo | 1985 |
Serotonin and dopamine turnover after acute and chronic morphine administration.
Topics: Animals; Brain; Brain Chemistry; Dopamine; Drug Tolerance; Homovanillic Acid; Humans; Hydroxyindolea | 1974 |
CSF monoamine metabolites in alcoholism: a comparative study with depression.
Topics: Adult; Aged; Alcoholism; Depression; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Ma | 1974 |
Noradrenaline and 5-hydroxytryptamine metabolism in six areas of rat brain during post-amphethamine depression.
Topics: Animals; Behavior, Animal; Brain; Depression; Depression, Chemical; Dextroamphetamine; Fluorometry; | 1974 |
Urinary excretion of monoamines and metabolites in patients dependent on and withdrawn from barbiturates.
Topics: Barbiturates; Catecholamines; Dopamine; Epinephrine; Female; Homovanillic Acid; Humans; Hydroxyindol | 1973 |
Brain serotonin turnover in morphine tolerant and dependent mice.
Topics: Animals; Brain; Brain Chemistry; Chlorine; Drug Tolerance; Humans; Hydroxyindoleacetic Acid; Male; M | 1970 |